Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Amino acid sequence disclosed in whole or in part; or...
Patent
1997-12-17
1999-12-07
Huff, Sheela
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Amino acid sequence disclosed in whole or in part; or...
514 12, 530324, 536 235, 435 723, A61K 3900, A61K 3800, C07H 2104, G01N 33574
Patent
active
059978724
ABSTRACT:
The invention relates to an isolated DNA sequence which codes for an antigen expressed by tumor cells which maybe recognized by cytotoxic T cells, leading to lysis of the tumor cells which express it. This invention also relates to vectors which are designed to encode the antigen expressed by tumor cells and also to cells transfected by the DNA sequence or vectors which comprise the DNA sequence. Various therapeutic and diagnostic uses arising out of the properties of the DNA and the antigen for which it codes are also part of this invention.
Boon-Falleur Thierry
De Smet Charles
Lucas Sophie
Eyler Yvonne
Huff Sheela
Ludwig Institute for Cancer Research
LandOfFree
Isolated nucleic acid molecule coding for tumor rejection antige does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated nucleic acid molecule coding for tumor rejection antige, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated nucleic acid molecule coding for tumor rejection antige will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-820617